PrecisionPhage
Phage genome bioinformatics software, lab services and a phage library for AMR and phage therapy research
Highlights
- Young companyFounded 2022
- New on EvolcAdded 2026-10-27
About PrecisionPhage
PrecisionPhage is a Finland-based biotech company that develops bacteriophage bioinformatics software and offers phage laboratory services. Phagenomics Core is a no-code tool for phage genome assembly and annotation, available under Free and Pro licences. Phagenomics BatchQC is a platform for verifying genome integrity, detecting contamination and producing regulatory reports in bacteriophage manufacturing. The company also maintains a phage library and offers phage isolation and characterisation, DNA preparation and sequencing, and phage laboratory R&D.
Customers named on the site include therapeutic developers, manufacturers, academic researchers and organisations exploring new phage applications. The company sells software licences, laboratory services and phage library licensing.
PrecisionPhage was founded in 2022 and is headquartered in Jyväskylä, Finland. It was established on academic research at two Finnish universities. The company reports more than 1600 phages in its library, over 2000 annotated phage genomes and over 6000 research-grade batches produced.
Product: Phagenomics Core genome assembly and annotation software; Phagenomics BatchQC GMP-compatible phage manufacturing QC platform; phage library and laboratory services
Jobs at PrecisionPhage
Leadership
- Aditya Jeevannavar · BioinformaticianSource: company website
- Johanna Ekholm · Chief Compliance OfficerSource: company website
- Juuli Peräkylä · Laboratory ManagerSource: company website
- Liisa Chisty · IPR SpecialistSource: company website
- Matthieu Bruneaux · BioinformaticianSource: company website
- Nitin Agrawal · Sales AssociateSource: company website
- Olli Pitkänen · Chief Development OfficerSource: company website
- Pauliina Lajunen · Chief Business OfficerSource: company website
More biotech & pharma companies
Primoceler
Hermetic glass packaging and laser bonding for active implantable device electronics, from prototype to series productionNew on EvolcProbiont
Develops organ-on-a-chip solutions to test cancer immunotherapy efficacy for personalized treatment assessmentNew on EvolcPuro Analytics
EDNA biodiversity monitoring for organisations: species detection, fish and forest surveys, lab analysis and reportsYoung companyNew on EvolcRappta Therapeutics
Develops first-in-class anti-cancer molecular glues that reactivate the tumor suppressor PP2A, for oncology drug developmentNew on EvolcReagena
Diagnostic tests and laboratory reagents for clinical, biotechnology, pharmaceutical and research organizationsNew on EvolcReBio Technologies
Develops targeted, locally delivered drug conjugates for ocular cancers, starting with uveal melanomaNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- AWS
- Cloudflare
- Google Tag Manager
- Webflow